First oral add-on to insulin for type 1 diabetes approved

The European Medicines Agency has recommended dapagliflozin as adjunct to insulin in overweight patients with type 1 diabetes.
The European Medicines Agency has recommended dapagliflozin as adjunct to insulin in overweight patients with type 1 diabetes.